Firm
To mark the EUIPO having processed five million EUTM and REUD applications, Managing IP speaks to the most prolific representatives to uncover how they stay at the top of their game
The merger marks Rouse’s second M&A deal within a month, and will provide access to Arnold & Siedsma’s UPC offering
The co-leaders of the firm’s new SEP practice group say the team will combine litigation and prosecution expertise to guide clients through cross-border challenges
Partners at three law firms explain why trade secrets cases are rising, and how litigation is giving clients a market advantage
Sponsored
Sponsored
-
Sponsored by Maiwald Intellectual PropertyFive female patent attorneys at Maiwald, spanning several age groups and practice areas, explain how the intellectual property firm encourages the career development of women and talented young professionals -
Sponsored by Bugnion SpAAndrea Cappai of Bugnion SpA considers the strengths and weaknesses of GlobalBlock and GlobalBlock+ as trademark protection tools and draws comparisons with several other options in the quest for a unified solution
-
Sponsored by Tilleke & GibbinsLoc Xuan Le, Duc Anh Tran, and Linh Duy Mai of T&G Law Firm LLC, the local associate firm of Tilleke & Gibbins in Vietnam, report on the country’s first criminal trial involving copyright and related rights infringement
-
Sponsored by Tilleke & GibbinsLinh Thi Mai Nguyen and Chi Lan Dang of Tilleke & Gibbins say regulations concerning the new Inspection and Appeal Department and a 2023 circular are steps towards improved handling of intellectual property appeals
-
Sponsored by Remfry & SagarAarti Aggarwal of Remfry & Sagar reports that a decision concerning a company licensed to use the Nokia brand name has confirmed that generic concepts or ideas cannot be protected through copyright
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Suvarna Pandey of RNA, Technology and IP Attorneys consider the implications of a High Court of Delhi ruling concerning a patented compound used to treat non-small cell lung cancer
